Enhanced Drug and Device Development by Targeting "Relief of Dyspnea"
Chest
.
2020 Aug;158(2):464-466.
doi: 10.1016/j.chest.2020.04.040.
Epub 2020 Jun 30.
Authors
Donald A Mahler
1
,
Sanjay Sethi
2
Affiliations
1
Geisel School of Medicine at Dartmouth, Hanover, and the Valley Regional Hospital, Claremont, NH. Electronic address: mahlerdonald@gmail.com.
2
Jacobs School of Medicine, University at Buffalo, State University of New York, Buffalo, NY.
PMID:
32619465
DOI:
10.1016/j.chest.2020.04.040
No abstract available
Publication types
Editorial
MeSH terms
Device Approval*
Drug Approval*
Dyspnea / prevention & control*
Humans
Outcome Assessment, Health Care*
United States